longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

MNMD

MNMD
14.8700.00%( 0.000 )

LongbridgeAI

Trump Order To Accelerate Treatments For Serious Mental Illness

rttnews
Apr 20, 2026 at 11:37 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

President Donald Trump has signed an Executive Order to accelerate access to treatments for serious mental illness. The Order directs the FDA to provide National Priority Vouchers for psychedelic drugs with Breakthrough Therapy designations, ensuring timely reviews and reducing delays in therapy access for patients with complex conditions.

Add as your preferred news source on Google

Add Now

President Donald Trump has signed an Executive Order that will accelerate access to treatments for patients with serious mental illness, reaffirming his commitment to advancing solutions that provide hope to Americans with devastating, complex, and treatment-resistant conditions.

The Order directs the Food and Drug Administration Commissioner to provide Commissioner's National Priority Vouchers to appropriate psychedelic drugs that have received Breakthrough Therapy designations for treating serious mental illnesses, and that meet the criteria of the National Priority Voucher Program. This will ensure that red tape does not delay the FDA's gold standard review of any potential therapy.

This article is part of our premium content offering.Subscribe with a RTTNews subscription.

Subscribe Now

Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Login to unlock447characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Compass Pathways

Compass Pathways

USCMPS

+0.91%

Mind Medicine MindMed

Mind Medicine MindMed

USMNMD

0.00%

AdvisorShares Psychedelics ETF

AdvisorShares Psychedelics ETF

USPSIL